{"link": "http://hdl.handle.net/10138/135978", "subject": "biokemia', 'biokemia", "wordcount": 24803, "major": "Glycan binding proteins in therapeutic mesenchymal stem cell research", "abstract": "Mesenchymal stem/stromal cells (MSCs) are multipotent adult stem cells that hold enormous therapeutic potential. They are currently in a focus of intense clinical and scientific investigation. MSCs are a promising cell type for various applications in the field of tissue engineering due to their multi-lineage differentiation capacity. Furthermore, one of their most interesting characteristics is that they possess immunomodulatory properties making these cells an attractive candidate for therapy of several immune-mediated disorders. MSCs are of nonembryonic origin and thus provide a less controversial and technically more feasible alternative for ESCs in future therapeutic applications. \\n\\nDue to their location on the cell surface, glycans are ideal molecules for identification, purification, and characterization of cells for therapeutic purposes. Methods to reliably and proficiently determine both the change in the presence of a specific glycan structures and the changes in the glycome profile of a cell, are needed. Glycan binding proteins in general serve as diagnostic tools in medical and scientific laboratories. High affinity and exquisite specificity are important factors for their successful use. \\n\\nThe aim of this study was to characterize the glycans on the surface of MSCs in order to find novel MSC specific glycan markers. Further goal was to develop antibodies specific for MSC surface glycans, including the novel MSC marker. \\n\\nAs described in the original publications of this study, we first characterized the glycome of MSCs and discovered that certain specific glycan epitopes are present only in MSCs, and not in cells differentiated from them. These epitopes include i antigen, which was further characterized to be a marker for umbilical cord blood derived MSCs. An antibody against the i antigen was generated using recombinant technology. Antibodies recognizing MSC surface glycans were also generated by utilizing hybridoma technology, using whole MSCs in the immunization. \\n\\nTaken together, these studies provide information of the changes in the glycome profile during MSC differentiation and describe a novel MSC marker. In these studies, we used two different methods to generate anti-glycan antibodies and emphasize the importance of thorough characterization of the binding properties of GBPs. The information of the characteristic glycosylation features of MSCs, and specific markers especially, can be used to isolate and characterize desired, therapeutically advantageous cell populations for distinct applications. Development of better glycan binding proteins will advance the field of cellular therapy and also the glycobiological research in general.', 'Mesenkymaaliset kantasolut (eli mesenkymaaliset stroomasolut) ovat monikykyisi\u00e4 soluja, jotka pystyv\u00e4t erilaistumaan useiksi erilaisiksi solutyypeiksi. Viime aikoina n\u00e4iden solujen tutkimus ja kliininen k\u00e4ytt\u00f6 on her\u00e4tt\u00e4nyt paljon huomiota ja kiinnostusta. Mesenkymaalinen kantasolu on lupaava solutyyppi moniin terapeuttisiin sovelluksiin. Erityisesti kudosteknologiset sovellukset k\u00e4ytt\u00e4v\u00e4t hyv\u00e4kseen mesenkymaalisten kantasolujen erilaistumiskyky\u00e4. Yksi mesenkymaalisten kantasolujen kiinnostavimmista piirteist\u00e4 on kuitenkin niiden vaikutus immuunivasteeseen ja mahdollinen k\u00e4ytt\u00f6 immuuniv\u00e4litteisten sairauksien, kuten k\u00e4\u00e4nteishyljint\u00e4reaktion hoidossa. \\n\\nSek\u00e4 tutkimus- ett\u00e4 terapiak\u00e4ytt\u00f6\u00f6n tarkoitetut solut t\u00e4ytyy voida tunnistaa, erist\u00e4\u00e4 ja karakterisoida hyvin. Solun pinnalla olevat sokerimolekyylit eli glykaanit tarjoavat t\u00e4h\u00e4n oivan mahdollisuuden. Sokerirakenteista voidaan tarkkailla yksitt\u00e4isten glykaanien esiintymisen muutoksia sek\u00e4 pinnan sokeriprofiilin kokonaismuutoksia. Tutkimusmenetelm\u00e4t ovat viime vuosina kehittyneet huimasti, mutta vaativat viel\u00e4 jatkuvaa kehityst\u00e4. Sokerirakenteita sitovat proteiinit (vasta-aineet ja lektiinit) ovat laboratorioissa yleisesti k\u00e4ytettyj\u00e4 diagnostisia ty\u00f6kaluja, ja soveltuvat hyvin solun pinnan sokereiden tutkimiseen. Tarkasti m\u00e4\u00e4ritetty sitoutumisspesifisyys ja riitt\u00e4v\u00e4n hyv\u00e4 sitoutumislujuus ovat merkitt\u00e4vi\u00e4 tekij\u00f6it\u00e4 glykaaneja sitovien proteiinien onnistuneelle k\u00e4yt\u00f6lle sek\u00e4 niiden avulla saatujen tulosten oikeellisuudelle. \\n\\nT\u00e4m\u00e4n tutkimuksen tarkoituksena oli kartoittaa mesenkymaalisten kantasolujen pinnan sokerirakenteita tavoitteena l\u00f6yt\u00e4\u00e4 spesifinen markkeri sek\u00e4 kehitt\u00e4\u00e4 vasta-aineita n\u00e4it\u00e4 rakenteita tunnistamaan. Ensiksi havaitsimme solun pinnan sokeriprofiilin muuttuvan solun erilaistuessa. Keskityimme tarkastelemaan lineaarista poly-LacNAc  rakennetta, eli i-antigeenia, jonka m\u00e4\u00e4r\u00e4 solun pinnalla v\u00e4heni huomattavasti solujen erilaistuessa. Tarkempi karakterisointi osoitti i-antigeenin olevan spesifinen markkeri mesenkymaalisille kantasoluille. Kehitimme i-antigeenin tunnistavan vasta-aineen rekombinanttitekniikalla sek\u00e4 mesenkymaalisen solun pinnan sokereille spesifisi\u00e4 vasta-aineita hybridoomatekniikalla. \\n\\nJotta soluterapiaa voidaan turvallisesti kehitt\u00e4\u00e4 lis\u00e4\u00e4ntyviin hoitotarpeisiin, tarvitaan tarkkoja karakterisointimenetelmi\u00e4 ja hyvi\u00e4 ty\u00f6kaluja solujen tunnistamiseen ja erist\u00e4miseen. Tietoa pinnan sokerirakenteiden muutoksista voidaan k\u00e4ytt\u00e4\u00e4 eristett\u00e4ess\u00e4 haluttuja solupopulaatiota eri terapiasovelluksiin. Sokerirakenteita sitovien proteiinien kehitt\u00e4minen edesauttaa sek\u00e4 soluterapian ett\u00e4 glykobiologisen tutkimuksen kehittymist\u00e4.", "faculty": "bioymp", "charcount": 143267, "commonwords": [["cells", 377], ["cell", 285], ["et", 242], ["al", 240], ["stem", 219], ["antibodies", 155], ["glycan", 154], ["mscs", 143], ["human", 141], ["surface", 140], ["glycans", 139], ["blood", 123], ["used", 105], ["binding", 102], ["mesenchymal", 102], ["specific", 98], ["also", 91], ["structures", 80], ["antigen", 78], ["different", 76]], "keywords": "", "unit": "bio- ja ymp\u00e4rist\u00f6tieteellinen tiedekunta, biotieteiden laitos', 'Helsingfors universitet, bio- och milj\u00f6vetenskapliga fakulteten, biovetenskapliga institutionen', 'University of Helsinki, Faculty of Biological and Environmental Sciences, Department of Biosciences, Department of Biosciences, Biochemistry', 'Finnish Red Cross Blood Service", "status": "doctor", "thesistype": "V\u00e4it\u00f6skirja (artikkeli)', 'Doctoral dissertation (article-based)', 'Doktorsavhandling (sammanl\u00e4ggning)', 'Text", "pagecount": 77, "title": "Glycan Binding Proteins in Therapeutic Mesenchymal Stem Cell Research", "language": "en", "author": "Hirvonen, Tia", "date": "2014-10-31", "distinctwords": 4833}